Pfizer and AstraZeneca announce new investments of nearly $1 billion…
PARIS (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday…
N2:PHAR1
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
Drugmaker AbbVie expects Humira volume erosion to worsen
By Leroy Leo and Christy Santhosh (Reuters) -AbbVie expects a drop in sales volumes of…
US FDA approves Daiichi, AstraZeneca drug for treatment of solid…
(Reuters) - The U.S. Food and Drug Administration on Friday gave accelerated approval for…
Toyota becomes Asia’s most shorted large-cap stock –…
MILAN (Reuters) - Automaker Toyota Motor Corp became the most shorted large-cap stock by…
US FDA approves Novo Nordisk’s Wegovy for lowering heart risks
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration…
Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics
By Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) - Novo Nordisk's widely used…
Bayer cuts dividends to legal minimum to reduce debt
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its…
Gilead to buy CymaBay for $4.3 billion in bets on liver disease…
By Bhanvi Satija (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for…
Pfizer posts surprise 4th quarter profit, but key products miss on…
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit…